AnalySource

What AnalySource does

AnalySource is a privately-held, Fayetteville-based drug pricing intelligence platform that has operated since 1996 as a subsidiary of DMD America. The company delivers tiered subscription access to the First Databank drug pricing database, exposing more than 90 searchable formulation, therapeutic classification, package, and pricing attributes per product for virtually every FDA-approved drug, including current, obsolete, and decades of historical pricing information. Its customers include pharmaceutical manufacturers, biotech firms, federal and state government agencies, consulting firms, and adjacent healthcare entities such as group purchasing organizations (GPOs), pharmacy benefit managers (PBMs), health plans, drug wholesalers, and retail chains.

The core platform is a column/row web portal with filtering, watch lists and alerts, onscreen report and graph previews with Excel exports, and FDA-approved drug indication data layered onto the First Databank feed. A separate State Compliance Services module, operated by the parent DMD America, builds and reviews drug price transparency forms for Colorado (HB19-1131), Connecticut (Public Act 23-171), and Vermont (Pharmaceutical Marketer Price Disclosure law), with nearly 20 years of experience in Vermont compliance. The company offers quarterly refresher training, advanced webinars, weekly e-newsletters covering pricing activity and FDA approvals, and direct phone/email support during East Coast business hours.

Revenue is generated primarily through multi-year subscription contracts across three tiers — Premier Plan for daily monitoring, Basic Plans for periodic lookups, and pay-as-you-go Special Requests for ad-hoc single data pulls — supplemented by custom-quoted state compliance services. The go-to-market combines enterprise field sales (15-minute introductory calls and 45-minute demos booked via an Outlook calendar) with inside sales phone/email support, with referral channels explicitly citing First Databank and word-of-mouth as top lead sources.

Name

AnalySource

Legal name

AnalySource

Website

https://analysource.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

11–50 employees

Short description

AnalySource is a web-based drug pricing intelligence platform, founded 1996 and subsidiary of DMD America, offering tiered subscription access to the First Databank drug pricing database for pharmaceutical manufacturers, biotech firms, government agencies, and consulting firms.

Ownership category

akta.pro rank

Product category

Drug Pricing Intelligence

NAICS

Web Search Portals and All Other Information Services (51929)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Pricing Operations & Analytics (Price Governance, Systems, Reporting) (HLAIAKAK)

akta.pro secondary industry

Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN)

Keywords

• Drug pricing database
• Pharmaceutical pricing intelligence
• Drug price transparency
• Healthcare data analytics
• Pharma market intelligence

Headquarters

HQ city

Fayetteville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Subscription Plans: Tiered subscription model providing access to First Databank drug pricing database. Plans include Premier Plan (recommended for day-to-day monitoring), Basic Plans (for periodic lookups), and Special Requests (infrequent pricing checks and single data pulls). All plans include over 90 searchable attributes and data points per product.
2. State Compliance Services: Full-service compliance program for state drug price transparency laws (Colorado, Connecticut, Vermont). Services include building and updating compliance forms, expert analysis of submitted forms, and ongoing compliance support. Pricing offered via quote.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

AnalySource is a web-based SaaS portal that delivers premier access to the First Databank drug pricing database, exposing over 90 searchable formulation, therapeutic classification, package, and pricing attributes for virtually every FDA-approved drug. Customers subscribe via tiered plans (Premier Plan, Basic Plans, Special Requests) and an ancillary State Compliance Services offering helps pharmaceutical marketers meet Colorado, Connecticut, and Vermont drug price transparency disclosure requirements.

Product overview

AnalySource is a web-based drug pricing intelligence platform offering tiered subscription access to the First Databank drug pricing database. The core portfolio consists of three product tiers: the Premier Plan (for daily monitoring and analysis), Basic Plans (for periodic lookups), and Special Requests (for ad-hoc single data pulls). All plans provide access to over 90 searchable formulation, therapeutic classification, package, and pricing attributes for FDA-approved drugs. An ancillary State Compliance Services module assists pharmaceutical companies with mandated drug price disclosure forms required by Colorado, Connecticut, and Vermont state laws.

Differentiator

Problem solved

Functional benefit

Products and services

• AnalySource Premier Plan Full-featured subscription providing access to the First Databank drug pricing database with more than 90 searchable formulation, therapeutic classification, package, and pricing attributes per product for virtually every FDA-approved drug. Designed for pharma, biotech, government, and consulting users who monitor and analyze drug pricing on a day-to-day basis.
• AnalySource Basic Plans Subscription tier for periodic routine drug pricing lookups, providing access to the First Databank drug pricing database with over 90 searchable attributes per product. Recommended for users with lower ongoing needs than Premier Plan subscribers.
• AnalySource Special Requests On-demand service for users who need infrequent drug pricing checks or single, specific data pulls from the First Databank drug pricing database without an ongoing subscription.
• State Compliance Services Full-service compliance program for pharmaceutical marketers required to disclose drug pricing under state transparency laws in Colorado (HB19-1131), Connecticut (Substitute House Bill No. 6669), and Vermont's Pharmaceutical Marketer Price Disclosure law. Services include building and updating required forms from the ground up, expert analysis of submitted forms, and ongoing compliance support with custom-quoted pricing.

Quantifiable outcome

• Saves time and effort by filtering in the portal instead of pulling down data and eliminating unnecessary fields

Named customers4 records

Segments5 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• First DatabankcoreTechnology or IntegrationFirst Databank is the underlying data provider for AnalySource's drug pricing database. AnalySource provides premier access to the First Databank drug pricing database, which includes pricing data for virtually every FDA-approved drug with over 90 searchable attributes per product.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• First Databank (FDB): First Databank is the underlying drug data provider that powers AnalySource's product. FDB also offers its own direct drug information and pricing solutions to hospitals, pharmacies, and health systems, making it both a critical partner and a direct competitor with the potential to disintermediate AnalySource's value-add layer.
• Wolters Kluwer (Medi-Span / Lexicomp): Wolters Kluwer operates Medi-Span and Lexicomp, which are among the most widely adopted drug pricing and drug information databases for hospitals, pharmacies, and pharma manufacturers. These products directly compete with AnalySource's First Databank-based offering for the same enterprise pharma and healthcare customer base.
• Truven Health Analytics (Red Book): Red Book (now part of Merative) provides drug pricing and average wholesale price (AWP) reference data widely used by pharma manufacturers and healthcare organizations. It competes with AnalySource in delivering curated, queryable drug pricing data to pharma commercial and government clients.
• Elsevier (Gold Standard Drug Database): Elsevier operates the Gold Standard Drug Database, which provides drug pricing, clinical, and reference information similar to AnalySource's First Databank-based product. It serves pharma manufacturers, PBMs, and government agencies with comparable use cases in drug pricing intelligence.
• IBM Micromedex: IBM Micromedex is an enterprise drug information and pricing reference used by hospitals, health systems, and pharma companies. It directly competes with AnalySource for healthcare decision-makers needing drug pricing, indication, and formulary data, though it operates at significantly larger scale.

Broad incumbents

• Veeva Systems: Veeva provides cloud software for the life sciences industry, including commercial and medical affairs solutions used by pharma manufacturers. While its core focus is CRM and content management, its commercial data offerings intersect with AnalySource's pricing intelligence use cases for pharma sales and marketing teams.
• Definitive Healthcare: Definitive Healthcare provides healthcare commercial intelligence and analytics to pharma, biotech, and medtech companies. While broader than AnalySource's drug pricing focus, it overlaps in serving pharma commercial teams needing pricing, market access, and competitive intelligence data.
• Cencora (formerly AmerisourceBergen): Cencora, one of the largest US pharmaceutical wholesalers and distribution services companies, operates drug pricing intelligence and analytics services for pharma manufacturers. It overlaps with AnalySource's drug manufacturer customer base in commercial pricing and supply chain decisions.
• IQVIA: IQVIA is the largest provider of healthcare and pharma analytics, with drug pricing, market access, and commercial intelligence products that compete for the same pharma manufacturer and government customer budgets as AnalySource, though at vastly greater scale and breadth.
• McKesson (RelayHealth / CoverMyMeds): McKesson operates pharmaceutical distribution and drug pricing/benefit services, including CoverMyMeds in ePrescribing. It serves many of the same pharma manufacturers and PBMs as AnalySource with broader drug pricing, access, and reimbursement offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/analysource
• LinkedInlinkedin.com/company/dmdamerica

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AnalySource